{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:26:51Z","timestamp":1754162811257,"version":"3.41.2"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this review is to identify recent advances in our understanding and management of immunoglobulin E (IgE)-mediated antibiotic allergy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Antibiotics remain a leading cause of fatal anaphylaxis reported to the FDA. However, recent advances have defined the features of adult and pediatric patients without true IgE-mediated allergy or any mechanism of anaphylaxis when tested. This has created opportunities to use direct challenges to disprove these allergies at the point-of-care and improves antibiotic stewardship. Additional advances have highlighted cross-reactive structural considerations within classes of drugs, in particular the R1 side-chain of cephalosporins, that appear to drive true immune-mediated cross-reactivity. Further advances in risk-based approaches to skin testing, phenotyping, and re-exposure challenges are needed to standardize antibiotic allergy evaluation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent advances in defining true IgE-mediated drug allergy have helped to identify patients unlikely to be skin-test positive. In turn, this has identified patients who can skip skin testing and proceed to direct ingestion challenge using history risk-based approaches. The ability to identify the small number of patients with true IgE-mediated allergy and study their natural history over time, as well as the vast majority without true allergy will facilitate important and novel mechanistic discoveries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001171","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T07:00:40Z","timestamp":1661756440000},"page":"609-615","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Advances in immunoglobulin E mediated antibiotic allergy"],"prefix":"10.1097","volume":"34","author":[{"given":"Christine R.F.","family":"Rukasin","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Phoenix Children's Hospital"},{"name":"Department of Child Health, University of Arizona College of Medicine-Phoenix"},{"name":"Division of Allergic Diseases, Mayo Clinic Arizona, Scottsdale"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center"},{"name":"Department of Pharmacology, Vanderbilt University School of Medicine"},{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt School of Medicine, Nashville, Tennessee, USA"},{"name":"Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary, Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anai.2016.05.017","article-title":"Redesigning the allergy module of the electronic health record","volume":"117","author":"Blumenthal","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.anai.2020.03.012","article-title":"Children with reported penicillin allergy: public health impact and safety of delabeling","volume":"124","author":"Vyles","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1017\/ice.2020.424","article-title":"The impact of beta-lactam allergy labels on hospitalized children","volume":"42","author":"Jones","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaip.2018.09.003","article-title":"Antibiotic allergy labels in children are associated with adverse clinical outcomes","volume":"7","author":"Lucas","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"e20170471","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13223-020-00501-6","article-title":"First pediatric electronic algorithm to stratify risk of penicillin allergy","volume":"16","author":"Roberts","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"819.e2","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-2497","article-title":"Antibiotic allergy in pediatrics","volume":"141","author":"Norton","year":"2018","journal-title":"Pediatrics"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"e13745","DOI":"10.1111\/pai.13745","article-title":"New diagnostic perspectives in the management of pediatric beta-lactam allergy","volume":"33","author":"Ariko\u011flu","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/cea.13707","article-title":"GRAded oral challenge for drug allergy evaluation-delabelling described through families\u2019 voices","volume":"50","author":"Protudjer","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jaip.2020.07.056","article-title":"Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins","volume":"9","author":"Stone","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial","volume":"7","author":"Mustafa","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaip.2017.10.008","article-title":"Natural history of benign nonimmediate allergy to beta-lactams in children: a prospective study in retreated patients after a positive and a negative provocation test","volume":"6","author":"Tonson la Tour","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"100602","DOI":"10.1016\/j.waojou.2021.100602","article-title":"75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results","volume":"14","author":"Joerg","year":"2021","journal-title":"World Allergy Organ J"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jaip.2020.11.032","article-title":"Evaluating immediate reactions to cephalosporins: time is of the essence","volume":"9","author":"Romano","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R20-20250730","first-page":"S2213","article-title":"Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks","author":"Koo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"2858.e16","DOI":"10.1016\/j.jaip.2020.04.059","article-title":"Penicillin allergy delabeling: a multidisciplinary opportunity","volume":"8","author":"Staicu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R22-20250730","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anai.2021.07.005","article-title":"Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule","volume":"128","author":"Piotin","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.jaip.2021.04.073","article-title":"Direct challenges for the evaluation of beta-lactam allergy: evidence and conditions for not performing skin testing","volume":"9","author":"Iammatteo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2022.01.041","article-title":"Low-risk penicillin allergy delabeling through direct oral challenge in immunocompromised and\/or multiple drug allergy labeled patients in a critical care setting","volume":"10","author":"Koo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1126.e1","DOI":"10.1016\/j.jaip.2019.09.022","article-title":"Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit","volume":"8","author":"Vyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1542\/hpeds.2020-001636","article-title":"A multidisciplinary quality improvement initiative to facilitate penicillin allergy delabeling among hospitalized pediatric patients","volume":"11","author":"Bauer","year":"2021","journal-title":"Hosp Pediatr"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"E394","DOI":"10.9778\/cmajo.20200077","article-title":"Amoxicillin oral provocation challenge in a primary care clinic: a descriptive analysis","volume":"9","author":"Gateman","year":"2021","journal-title":"CMAJ Open"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"3634.e1","DOI":"10.1016\/j.jaip.2020.07.007","article-title":"Penicillin allergy labels drive perioperative prophylactic antibiotic selection in orthopedic procedures","volume":"8","author":"Coleman","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2022.03.015","article-title":"Safety of cefazolin for perioperative prophylaxis in patients with penicillin allergy labels","volume":"129","author":"Cooper","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.surg.2021.02.063","article-title":"Comparison of immediate hypersensitivity reactions to preoperative antibiotics in patients labeled as penicillin allergic","volume":"170","author":"Fosnot","year":"2021","journal-title":"Surgery"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jaip.2019.12.016","article-title":"A streamlined approach to optimize perioperative antibiotic prophylaxis in the setting of penicillin allergy labels","volume":"8","author":"Kuruvilla","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"e210021","DOI":"10.1001\/jamasurg.2021.0021","article-title":"Assessment of the frequency of dual allergy to penicillins and cefazolin","volume":"156","author":"Sousa-Pinto","year":"2021","journal-title":"JAMA Surg"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/CORR.0000000000001739","article-title":"Antibiotic stewardship interventions improve choice of antibiotic prophylaxis in total joint arthroplasty in patients with reported penicillin allergies","volume":"479","author":"Jones","year":"2021","journal-title":"Clin Orthop Relat Res"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.surg.2021.03.022","article-title":"Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital","volume":"170","author":"Grant","year":"2021","journal-title":"Surgery"},{"key":"R37-20250730","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050694","article-title":"Increasing cefazolin use for perioperative antibiotic prophylaxis in penicillin-allergic children","volume":"149","author":"Isserman","year":"2022","journal-title":"Pediatrics"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.anai.2020.03.013","article-title":"Preoperative penicillin allergy testing in patients undergoing cardiac surgery","volume":"124","author":"Plager","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.bja.2019.01.026","article-title":"Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations","volume":"123","author":"Savic","year":"2019","journal-title":"Br J Anaesth"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.arth.2020.08.045","article-title":"Preoperative allergy testing for patients reporting penicillin and cephalosporin allergies is cost-effective in preventing infection after total knee and hip arthroplasty","volume":"36","author":"Pagani","year":"2021","journal-title":"J Arthroplast"},{"issue":"(Suppl B)","key":"R41-20250730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1407.R1","article-title":"2019 John Charnley Award: increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis","volume":"101-B","author":"Wyles","year":"2019","journal-title":"Bone Jt J"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"1994.e5","DOI":"10.1016\/j.jaip.2020.11.063","article-title":"Cephalosporin hypersensitivity: descriptive analysis cross-reactivity, and risk factors","volume":"9","author":"Touati","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"(3)","key":"R43-20250730","first-page":"298","article-title":"Risk stratification as a predictive factor for cephalosporin allergy: a case-controlled study","author":"Suleyman","journal-title":"Int Arch Allergy Immunol"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000495302","article-title":"The diagnosis of ceftriaxone hypersensitivity in a paediatric population","volume":"178","author":"Mori","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"292","DOI":"10.18176\/jiaci.0669","article-title":"Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to quinolones","volume":"31","author":"Dona","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaip.2020.09.017","article-title":"Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic","volume":"9","author":"Krantz","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.iac.2022.01.003","article-title":"Skin testing approaches for immediate and delayed hypersensitivity reactions","volume":"42","author":"Barbaud","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"3208.e1","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Bluestein","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"757.e4","DOI":"10.1016\/j.jaip.2019.07.003","article-title":"Oral challenge with trimethoprim-sulfamethoxazole in patients with \u201csulfa\u201d antibiotic allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1016\/j.jaip.2021.07.027","article-title":"Reply to \u201c\u2019The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy\u201d","volume":"9","author":"Krantz","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaip.2021.11.024","article-title":"A single- or two-step challenge versus a six-step challenge in non-HIV-infected patients with a sulfonamide antibiotic allergy label: a retrospective case series","volume":"10","author":"Motoa","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.anai.2021.04.001","article-title":"Outcome of trimethoprim-sulfamethoxazole (TMP-SMX) challenge in previously reported sulfa antibiotic allergic patients","volume":"127","author":"Benesch","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jaip.2021.05.046","article-title":"The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy","volume":"9","author":"Rose","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"e13461","DOI":"10.1111\/tid.13461","article-title":"Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers","volume":"23","author":"Lum","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2019-2256","article-title":"Nonbeta-lactam antibiotic hypersensitivity reactions","volume":"145","author":"Grinlington","year":"2020","journal-title":"Pediatrics"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/pai.13588","article-title":"Clarithromycin hypersensitivity in children: Is there a link with \u03b2-lactam hypersensitivity?","volume":"32","author":"Suleyman","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/INF.0000000000002746","article-title":"Drug provocation tests for assessing antibiotic hypersensitivity: is shorter also better?","volume":"39","author":"Garcia-Boyano","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"2501.e2","DOI":"10.1016\/j.jaip.2021.01.023","article-title":"Implementing a penicillin allergy de-labelling service for the obstetric population","volume":"9","author":"Zhang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaip.2020.10.063","article-title":"Penicillin allergy assessment in pregnancy: safety and impact on antibiotic use","volume":"9","author":"Wolfson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jaip.2022.03.025","article-title":"Safety of direct oral challenge to amoxicillin in pregnant patients at a canadian tertiary hospital","volume":"10","author":"Mak","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anai.2021.05.022","article-title":"Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis","volume":"127","author":"Anstey","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"e13175","DOI":"10.1111\/tid.13175","article-title":"Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients","volume":"21","author":"Modi","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"R63-20250730","first-page":"3209","article-title":"Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer","volume":"73","author":"Trubiano","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"2185.e1","DOI":"10.1016\/j.jaip.2019.03.025","article-title":"Safety, efficacy, and clinical impact of penicillin skin testing in immunocompromised cancer patients","volume":"7","author":"Taremi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"3631.e1","DOI":"10.1016\/j.jaip.2020.06.060","article-title":"Antibiotic adverse reactions in adult cystic fibrosis patients","volume":"8","author":"Anstey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/pai.13206","article-title":"The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients","volume":"31","author":"Braun","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"R68-20250730","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anai.2018.11.014","article-title":"Drug allergy in children and adults: is it the double X chromosome?","volume":"122","author":"Norton","year":"2018","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:05:07Z","timestamp":1753898707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001171","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"type":"print","value":"1040-8703"},{"type":"electronic","value":"1531-698X"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}